Pseudojervine

CAS No. 36069-05-3

Pseudojervine( Jervin-3-glucoside | O-beta-D-Glucopyranosyljervine )

Catalog No. M29248 CAS No. 36069-05-3

Pseudojervine is derived from Veratrum nigrum L. Pseudojervine exhibits feeble inhibition activity against platelet aggregation.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
2MG 89 In Stock
5MG 158 In Stock
10MG 259 In Stock
100MG Get Quote In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Pseudojervine
  • Note
    Research use only, not for human use.
  • Brief Description
    Pseudojervine is derived from Veratrum nigrum L. Pseudojervine exhibits feeble inhibition activity against platelet aggregation.
  • Description
    Pseudojervine is derived from Veratrum nigrum L. Pseudojervine exhibits feeble inhibition activity against platelet aggregation.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    Jervin-3-glucoside | O-beta-D-Glucopyranosyljervine
  • Pathway
    Others
  • Target
    Platelet aggregation
  • Recptor
    Platelet aggregation
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    36069-05-3
  • Formula Weight
    587.754
  • Molecular Formula
    C33H49NO8
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    C[C@@H]1[C@@H]2NC[C@@H](C)C[C@H]2O[C@]11CC[C@H]2[C@@H]3CC=C4C[C@H](CC[C@]4(C)[C@H]3C(=O)C2=C1C)O[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • Mutant EGFR inhibito...

    Mutant EGFR inhibitor is a selective and potent Mutated EGFR inhibitor, inhibits L858R activating mutant, the Exonl9 deletion activating mutant and the T790M resistance mutant.

  • ENFENAMIC ACID

    Enfenamic acid is a platelet aggregation inhibitor and with antirheumatic.Dose-matched comparison between zinc-salt of enfenamic acid and the parent compound was carried out in experimentally wounded male albino rats bearing either sutured incision, dead-space or excision wounds.

  • Etizolam

    Etizolam is a selective platelet-activating factor (PAF) antagonist.